Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Watchman LAA Closure vs Standard Therapy in AF Patients after PCI
NCT02492230Phase 2Unknown
- Sponsor
- E. Meshalkin National Medical Research Centre
- Start
- May 2015
- Primary completion
- Mar 2016
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in Atrial fibrillation (AFib) and myocardial infarction (MI), sponsored by E. Meshalkin National Medical Research Centre. Primary endpoint: Number of patients with bleeding according to TIMI and GUSTO scales at 12 months. Status: unknown.
02
Conditions
Atrial fibrillation (AFib)myocardial infarction (MI)
Beyond the preview
Go deeper on NCT02492230.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02492230.